Price Chart


Price Chart

Profile

Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. Its technology platform, IMMray, focuses on the early diagnosis of cancer, predicts disease progression, and monitors therapeutic responsiveness of cancer. The company was founded by Carl Arne Krister Borrebaeck on May 24, 2007 and is headquartered in Lund, Sweden.
URL http://www.immunovia.com
Investor Relations URL N/A
HQ State/Province Skane
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release N/A
Last Earnings Release May. 14, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. Its technology platform, IMMray, focuses on the early diagnosis of cancer, predicts disease progression, and monitors therapeutic responsiveness of cancer. The company was founded by Carl Arne Krister Borrebaeck on May 24, 2007 and is headquartered in Lund, Sweden.
URL http://www.immunovia.com
Investor Relations URL N/A
HQ State/Province Skane
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release N/A
Last Earnings Release May. 14, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A